FT011 is a direct anti-fibrotic small molecule that reduces cardiac remodeling and dysfunction in models of diabetic cardiomyopathy. It is a research tool for studying fibrosis in cardiovascular and metabolic disease research, with demonstrated efficacy in both in vivo and in vitro experimental systems.